[PDF][PDF] Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
…, D Lai, H Hou, Z Xu, B Zhang, H Chen, C Yu, J Xue… - Cell reports, 2021 - cell.com
To fully decipher the immunogenicity of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) Spike protein, it is essential to assess which part is highly immunogenic in a …
(SARS-CoV-2) Spike protein, it is essential to assess which part is highly immunogenic in a …
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections
…, Z Xu, B Zhang, H Chen, J Xue… - Allergy, 2021 - Wiley Online Library
Background The missing asymptomatic COVID‐19 infections have been overlooked because
of the imperfect sensitivity of the nucleic acid testing (NAT). Globally understanding the …
of the imperfect sensitivity of the nucleic acid testing (NAT). Globally understanding the …
[HTML][HTML] Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination …
ML Ma, DW Shi, Y Li, W Hong, DY Lai, JB Xue… - Cell Discovery, 2021 - nature.com
One of the best ways to control COVID-19 is vaccination. Among the various SARS-CoV-2
vaccines, inactivated virus vaccines have been widely applied in China and many other …
vaccines, inactivated virus vaccines have been widely applied in China and many other …
[HTML][HTML] Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients
…, Y Ren, M Ma, B Zhang, H Chen, C Yu, J Xue… - Cellular & Molecular …, 2021 - nature.com
Serological tests play an essential role in monitoring and combating the COVID-19 pandemic.
Recombinant spike protein (S protein), especially the S1 protein, is one of the major …
Recombinant spike protein (S protein), especially the S1 protein, is one of the major …
[PDF][PDF] Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins
…, X Wang, J Wu, M Ma, B Zhang, H Chen, C Yu, J Xue… - Cell Reports, 2021 - cell.com
The immunogenicity of the SARS-CoV-2 proteome is largely unknown, especially for non-structural
proteins and accessory proteins. In this study, we collect 2,360 COVID-19 sera and …
proteins and accessory proteins. In this study, we collect 2,360 COVID-19 sera and …
[HTML][HTML] Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
J Xue, D Lai, H Jiang, H Qi, S Guo, Y Zhu, H Xu, J Zhou… - Cell Discovery, 2022 - nature.com
Dear Editor, The Omicron variant (B. 1.1. 529) possesses~ 32 mutations in its spike protein,
and at least 15 amino acid changes in the receptor-binding domain (RBD) 1. The Omicron …
and at least 15 amino acid changes in the receptor-binding domain (RBD) 1. The Omicron …
Current advances in antibody‐based serum biomarker studies: From protein microarray to phage display
H Qi, J Xue, D Lai, A Li, S Tao - PROTEOMICS–Clinical …, 2022 - Wiley Online Library
Purpose This review aims to summarize the technological advances in the field of antibody‐based
biomarker studies by proteome microarray and phage display. In addition, the …
biomarker studies by proteome microarray and phage display. In addition, the …
COVID-ONE-hi: the one-stop database for COVID-19-specific humoral immunity and clinical parameters
…, M Ma, B Zhang, H Chen, C Yu, J Xue… - Genomics …, 2021 - academic.oup.com
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard
to symptoms and mortality rates among populations. Humoral immunity plays critical roles …
to symptoms and mortality rates among populations. Humoral immunity plays critical roles …
[HTML][HTML] Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients
…, B Zhang, H Chen, Z Ouyang, J Xue… - Journal of Advanced …, 2022 - Elsevier
Introduction The COVID-19 global pandemic is far from ending. There is an urgent need to
identify applicable biomarkers for early predicting the outcome of COVID-19. Growing …
identify applicable biomarkers for early predicting the outcome of COVID-19. Growing …
Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy
…, L Yang, W Hong, L Dan-Yun, X Jun-Biao… - Cell …, 2021 - search.proquest.com
One of the best ways to control COVID-19 is vaccination. Among the various SARS-CoV-2
vaccines, inactivated virus vaccines have been widely applied in China and many other …
vaccines, inactivated virus vaccines have been widely applied in China and many other …
